Our Patent Litigation team is a proud partner to the world’s most innovative life sciences and technology companies. Our experience successfully handling high-stakes patent matters, joined with Paul, Weiss's legendary litigation capabilities, enable us to provide comprehensive strategies to protect our clients’ most valuable innovations that extend well beyond traditional patent litigation.
Intellectual Property Litigation: Restricting Intangible IP Exports: Congress Left as Judge
June 14, 2007 Full PDF
Litigation partner Lew Clayton's "Intellectual Property Litigation" column appeared in the June 14 New York Law Journal. The article discusses recent opinions in which the U.S. Supreme Court overruled Federal Circuit interpretations of patent law, making it more difficult to obtain and enforce patents. The High Court's decisions appear to reflect an underlying view that the U.S. patent process stifles innovation and competition by issuing and enforcing too many weak patents. Associate Susanna Buergel assisted in the preparation of this article.